Private Equity
A 2% management fee may be the venture industry standard. But today, it appears that a majority of firms use something different.
2 min read · 09 December 2013
Rena M. Agle 12.00 Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin;} Survey of venture investment terms shows broad differences among firms
2 min read · 06 December 2013
After a long slog, the firm has six portfolio companies go IPO in past 14 months
4 min read · 18 November 2013
8 min read · 14 November 2013
Survey finds t hat VC investments returned an average of 5.9% dur 2013 fiscal year
1 min read · 13 November 2013
A number of companies, including LinkedIn and Tableau Software, have carried out large secondary offerings in recent weeks
1 min read · 12 November 2013
Couples who launch startups together face a lot of hurdles – but they also have a track record of creating some of the most successful venture-backed companies around.
2 min read · 11 November 2013
Couples who launch startups together face a lot of hurdles – but they also have a track record of creating some of the most successful venture-backed companies around.
3 min read · 11 November 2013
It did not come easily. But finally, its day has arrived. Enrollment opened in October for the controversial centerpiece of the U.S. Affordable Care Act, which directs individuals without health insurance to find coverage through state-run exchanges.
2 min read · 28 October 2013
Strong gains by mid and large-cap biotech stocks this year have fueled a resurgence in IPOs of VC-backed life science companies
3 min read · 28 October 2013
